387 related articles for article (PubMed ID: 26382742)
1. Medical Device Safety and Surgical Dissemination of Unrecognized Uterine Malignancy: Morcellation in Minimally Invasive Gynecologic Surgery.
Hall T; Lee SI; Boruta DM; Goodman A
Oncologist; 2015 Nov; 20(11):1274-82. PubMed ID: 26382742
[TBL] [Abstract][Full Text] [Related]
2. Uterine Morcellation: Fact and Fiction Surrounding the Recent Controversy.
Winner B; Biest S
Mo Med; 2017; 114(3):176-180. PubMed ID: 30228576
[TBL] [Abstract][Full Text] [Related]
3. [A critical assessment of morcellation in case of uterine malignancies and its impact on gynecologic surgery: From "precautionary principle" to "realism"].
Guyon F; Cordeiro Vidal G; Babin G; Stoeckle E; Querleu D
Bull Cancer; 2016 Jan; 103(1):96-103. PubMed ID: 26657189
[TBL] [Abstract][Full Text] [Related]
4. Morcellation of undiagnosed uterine sarcoma: A critical review.
Bogani G; Chiappa V; Ditto A; Martinelli F; Donfrancesco C; Indini A; Lorusso D; Raspagliesi F
Crit Rev Oncol Hematol; 2016 Feb; 98():302-8. PubMed ID: 26672915
[TBL] [Abstract][Full Text] [Related]
5. Long-term sequelae of unconfined morcellation during laparoscopic gynecological surgery.
Cohen A; Tulandi T
Maturitas; 2017 Mar; 97():1-5. PubMed ID: 28159054
[TBL] [Abstract][Full Text] [Related]
6. Reducing the spread of occult uterine sarcoma at the time of minimally invasive gynecologic surgery.
Wong M; De Wilde RL; Isaacson K
Arch Gynecol Obstet; 2018 Feb; 297(2):285-293. PubMed ID: 29128980
[TBL] [Abstract][Full Text] [Related]
7. Risk, risk reduction and management of occult malignancy diagnosed after uterine morcellation: a commentary.
Lynam S; Young L; Morozov V; Rao G; Roque DM
Womens Health (Lond); 2015 Nov; 11(6):929-44. PubMed ID: 26673851
[TBL] [Abstract][Full Text] [Related]
8. No. 371-Morcellation During Gynaecologic Surgery: Its Uses, Complications, and Risks of Unsuspected Malignancy.
Murji A; Scott S; Singh SS; Bougie O; Leyland N; Laberge PY; Vilos GA
J Obstet Gynaecol Can; 2019 Jan; 41(1):116-126. PubMed ID: 30580824
[TBL] [Abstract][Full Text] [Related]
9. Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation.
Multinu F; Casarin J; Hanson KT; Angioni S; Mariani A; Habermann EB; Laughlin-Tommaso SK
JAMA Surg; 2018 Jun; 153(6):e180141. PubMed ID: 29641835
[TBL] [Abstract][Full Text] [Related]
10. Sarcoma Risk in Uterine Surgery in a Tertiary University Hospital in Germany.
Kundu S; Zachen M; Hertel H; Hillemanns P; Soergel P
Int J Gynecol Cancer; 2017 Jun; 27(5):961-966. PubMed ID: 28498262
[TBL] [Abstract][Full Text] [Related]
11. The Morcellation Debate: The History and the Science.
Adelman MR
Clin Obstet Gynecol; 2015 Dec; 58(4):710-7. PubMed ID: 26512438
[TBL] [Abstract][Full Text] [Related]
12. Complication rate of uterine morcellation in laparoscopic supracervical hysterectomy: a retrospective cohort study.
Smits RM; De Kruif JH; Van Heteren CF
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():179-82. PubMed ID: 26943477
[TBL] [Abstract][Full Text] [Related]
13. Morcellation complications: From direct trauma to inoculation.
Noel NL; Isaacson KB
Best Pract Res Clin Obstet Gynaecol; 2016 Aug; 35():37-43. PubMed ID: 26879674
[TBL] [Abstract][Full Text] [Related]
14. Electric morcellation-related reoperations after laparoscopic myomectomy and nonmyomectomy procedures.
Pereira N; Buchanan TR; Wishall KM; Kim SH; Grias I; Richard SD; Della Badia CR
J Minim Invasive Gynecol; 2015 Feb; 22(2):163-76. PubMed ID: 25218993
[TBL] [Abstract][Full Text] [Related]
15. A critical assessment of morcellation and its impact on gynecologic surgery and the limitations of the existing literature.
Liu FW; Galvan-Turner VB; Pfaendler KS; Longoria TC; Bristow RE
Am J Obstet Gynecol; 2015 Jun; 212(6):717-24. PubMed ID: 25582101
[TBL] [Abstract][Full Text] [Related]
16. Assessing the risk of laparoscopic morcellation of occult uterine sarcomas during hysterectomy and myomectomy: Literature review and the ISGE recommendations.
Sizzi O; Manganaro L; Rossetti A; Saldari M; Florio G; Loddo A; Zurawin R; van Herendael B; Djokovic D
Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():30-38. PubMed ID: 29149644
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic power morcellation of presumed fibroids.
Brolmann HA; Sizzi O; Hehenkamp WJ; Rossetti A
Minerva Ginecol; 2016 Jun; 68(3):352-63. PubMed ID: 26799759
[TBL] [Abstract][Full Text] [Related]
18. Surgical cytoreduction for disseminated benign disease after open power uterine morcellation.
Ramos A; Fader AN; Long Roche K
Obstet Gynecol; 2015 Jan; 125(1):99-102. PubMed ID: 25560110
[TBL] [Abstract][Full Text] [Related]
19. Impact of the 2014 Food and Drug Administration Warnings Against Power Morcellation.
Lum DA; Sokol ER; Berek JS; Schulkin J; Chen L; McElwain CA; Wright JD
J Minim Invasive Gynecol; 2016; 23(4):548-56. PubMed ID: 26827905
[TBL] [Abstract][Full Text] [Related]
20. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
